Amesite INC 10-Q quarterly reports

Amesite Inc. reported increased revenue and reduced net loss for the nine months ended March 31, 2026, while addressing Nasdaq listing compliance.

Amesite Inc. significantly narrowed its net loss and increased revenue in Q1 2026, driven by a strategic shift to AI-driven healthcare solutions, despite ongoing 'going concern' doubts.

Amesite Inc. reports a net loss for Q3 2025, but highlights a strategic shift towards AI-driven solutions and a reduction in cash burn.

Amesite Inc. reports a decrease in revenue for the six months ended December 31, 2024, alongside a strategic pivot to grow its customer base and reduce losses.

Amesite Inc. has amended its quarterly report to disclose material weaknesses in its internal controls over financial reporting as of June 30, 2024.

Amesite Inc. reports a net loss of $908,045 for the quarter ended September 30, 2024, alongside a strategic pivot towards AI-powered solutions and cost reductions.

Amesite Inc. reported a decrease in revenue and continued net losses for the quarter ended March 31, 2024, while also highlighting cost reduction efforts and a focus on key markets.

Amesite Inc. reports a reduced net loss for the six months ended December 31, 2023, driven by cost-saving initiatives and improved operational efficiencies.